These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37789170)

  • 1. Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection.
    Wranke A; Heidrich B; Deterding K; Hupa-Breier KL; Kirschner J; Bremer B; Cornberg M; Wedemeyer H
    Hepatol Int; 2023 Dec; 17(6):1359-1367. PubMed ID: 37789170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection?
    Abbas Z; Qureshi M; Hamid S; Jafri W
    Saudi J Gastroenterol; 2012; 18(1):18-22. PubMed ID: 22249087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis D: A Review.
    Negro F; Lok AS
    JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
    Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
    PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
    Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
    J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
    Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
    Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review.
    Baskiran A; Atay A; Baskiran DY; Akbulut S
    J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region].
    Isaeva OV; Il'chenko LY; Saryglar AA; Karlsen AA; Kyuregyan KK; Mikhailov MI
    Vopr Virusol; 2021 Mar; 66(1):74-83. PubMed ID: 33683068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
    Lampertico P; Invernizzi F; Viganò M; Loglio A; Mangia G; Facchetti F; Primignani M; Jovani M; Iavarone M; Fraquelli M; Casazza G; de Franchis R; Colombo M
    J Hepatol; 2015 Nov; 63(5):1118-25. PubMed ID: 26100495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral treatment and liver-related complications in hepatitis delta.
    Wranke A; Serrano BC; Heidrich B; Kirschner J; Bremer B; Lehmann P; Hardtke S; Deterding K; Port K; Westphal M; Manns MP; Cornberg M; Wedemeyer H
    Hepatology; 2017 Feb; 65(2):414-425. PubMed ID: 27770553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
    Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
    J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
    Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
    Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta.
    Romeo R; Foglieni B; Casazza G; Spreafico M; Colombo M; Prati D
    PLoS One; 2014; 9(3):e92062. PubMed ID: 24658127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
    J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis.
    Kong Y; Sun Y; Wu X; Zhou J; Wang H; Ding H; Xie W; Chen G; Ma A; Piao H; Xu X; Jiang W; Feng B; Ou X; You H; Lee SS; Jia J
    Hepatol Int; 2023 Dec; 17(6):1350-1358. PubMed ID: 37597121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation of hepatitis D in Pakistani children.
    Abbas Z; Soomro GB; Hassan SM; Luck NH
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1098-103. PubMed ID: 25089545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.